NO20052267L - Forbindelser, Preparater og Metoder - Google Patents

Forbindelser, Preparater og Metoder

Info

Publication number: NO20052267L
Authority: NO; Norway
Prior art keywords: preparations; compounds; methods; ksp; triazol
Prior art date: 2002-10-11

Application number

NO20052267A

Other languages

English (en)

Norwegian (no)

Inventor

Jr David John C Morgans

Dashyant Dhanak

Gustave Bergnes

Steven David Knight

Xianping Qian

Original Assignee

Cytokinetics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-11

Filing date

2005-05-10

Publication date

2005-05-31

2005-05-10 Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc

2005-05-31 Publication of NO20052267L publication Critical patent/NO20052267L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20052267A 2002-10-11 2005-05-10 Forbindelser, Preparater og Metoder NO20052267L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US41788902P	2002-10-11	2002-10-11
PCT/US2003/031413 WO2004032840A2 (en)	2002-10-11	2003-10-02	Compounds, compositions, and methods

Publications (1)

Publication Number	Publication Date
NO20052267L true NO20052267L (no)	2005-05-31

Family

ID=32094113

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052267A NO20052267L (no)	2002-10-11	2005-05-10	Forbindelser, Preparater og Metoder

Country Status (19)

Country	Link
US (1)	US7476743B2 (de)
EP (1)	EP1558588A4 (de)
JP (1)	JP2006502219A (de)
KR (1)	KR20050075356A (de)
CN (1)	CN1726198A (de)
AR (1)	AR044193A1 (de)
AU (1)	AU2003282665A1 (de)
BR (1)	BR0315247A (de)
CA (1)	CA2501938A1 (de)
IL (1)	IL167936A0 (de)
IS (1)	IS7798A (de)
MX (1)	MXPA05003830A (de)
NO (1)	NO20052267L (de)
NZ (1)	NZ539643A (de)
PL (1)	PL375889A1 (de)
RU (1)	RU2005114491A (de)
TW (1)	TW200418818A (de)
WO (1)	WO2004032840A2 (de)
ZA (1)	ZA200503733B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200612958A (en) *	2004-06-18	2006-05-01	Chiron Corp	Substituted imidazole derivatives
BRPI0514390A (pt)	2004-08-18	2008-06-10	Astrazeneca Ab	enanciÈmero de um composto ou um sal farmacêuticamente aceitável ou um éster hidrolisável in vivo do mesmo, uso do mesmo, métodos para o tratamento de cáncer, para produzir um efeito inibidor de eg5 em um animal de sangue quente e para tratar doenças, e, composição farmacêutica
DE102006023337A1 (de) *	2006-05-18	2007-11-22	Merck Patent Gmbh	Triazolderivate II
JP5343363B2 (ja) *	2008-01-31	2013-11-13	アイシン精機株式会社	シートクッション調整装置
CN101643451B (zh) *	2008-08-07	2013-03-06	浙江海正药业股份有限公司	过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法
WO2011128381A1 (en)	2010-04-15	2011-10-20	Novartis Ag	Triazole compounds as ksp inhibitors
WO2012095691A1 (en) *	2011-01-15	2012-07-19	Jubilant Life Sciences Ltd.	An improved process for producing aminopyridines
US9505728B2 (en)	2012-03-09	2016-11-29	Inception 2, Inc.	Triazolone compounds and uses thereof
SG11201504622PA (en)	2012-12-20	2015-07-30	Inception 2 Inc	Triazolone compounds and uses thereof
CA2921420A1 (en)	2013-09-06	2015-03-12	Inception 2, Inc.	Triazolone compounds and uses thereof
BR112017027813A2 (pt)	2015-06-22	2018-08-28	Bayer Pharma Aktiengesellschaft	conjugados de agente de ligação-droga (adcs) e conjugados de agente de ligação-pró-droga (apdcs) tendo grupos enzimaticamente cliváveis
TW201722958A (zh) *	2015-09-15	2017-07-01	葛蘭素史克智慧財產（第二）有限公司	化學化合物
IL310558A (en)	2016-12-21	2024-03-01	Bayer Pharma AG	Drug-antibody conjugates with enzymatically cleavable groups
WO2023192499A1 (en) *	2022-03-30	2023-10-05	Primefour Therapeutics, Inc.	Nucleosides for treating cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE793532A (fr) *	1971-12-29	1973-06-29	Upjohn Co	Nouvelles 1,2,4-triazol-3-ones et leur preparation
US3748339A (en) *	1972-05-05	1973-07-24	Upjohn Co	2-(3-(1-(dimethylamino)alkyl)-1,5-dihydro-5-oxo - 1 - substituted-4h-1,2,4-triazol-4-yl)benzophenone and process
IT1068010B (it) *	1976-11-17	1985-03-21	Montedison Spa	Nuovi esteri fosforici derivati dall' 1-2-4 triazolo ad azione insetticida,nematocida e acaricida e loro preparazione
NL7712430A (nl)	1976-11-17	1978-05-19	Montedison Spa	Nieuwe fosforzuuresters, afgeleid van 1.2.4- -triazool, met een insecticide, nematocide en acaricide werking en werkwijze ter bereiding daarvan.
US4487773A (en) *	1981-03-16	1984-12-11	Mead Johnson & Company	1,2,4-Triazol-3-one antidepressants
US5250558A (en) *	1992-01-28	1993-10-05	Merck & Co., Inc.	Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
GB9211193D0 (en) *	1992-05-27	1992-07-08	Merck Sharp & Dohme	Therapeutic agents
IL106142A (en) *	1992-06-29	1997-03-18	Merck & Co Inc	Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them
EP0858444A4 (de) *	1995-10-18	1999-12-01	Merck & Co Inc	Cyclopentyl-tachykininreceptorantagonisten
JP2002234874A (ja) *	2000-09-26	2002-08-23	Tanabe Seiyaku Co Ltd	５−フェニルベンジルアミン誘導体、その製法及びその合成中間体
AU2002228760A1 (en) *	2000-10-26	2002-05-06	Merck & Co., Inc.	Mammalian metabolites of a tachykinin receptor antagonist
CN100421665C (zh) *	2002-06-14	2008-10-01	麦克公司	有丝分裂驱动蛋白抑制剂

2003
- 2003-10-02 US US10/529,634 patent/US7476743B2/en not_active Expired - Fee Related
- 2003-10-02 AU AU2003282665A patent/AU2003282665A1/en not_active Abandoned
- 2003-10-02 PL PL03375889A patent/PL375889A1/xx unknown
- 2003-10-02 NZ NZ539643A patent/NZ539643A/en unknown
- 2003-10-02 MX MXPA05003830A patent/MXPA05003830A/es unknown
- 2003-10-02 CA CA002501938A patent/CA2501938A1/en not_active Abandoned
- 2003-10-02 RU RU2005114491/04A patent/RU2005114491A/ru not_active Application Discontinuation
- 2003-10-02 KR KR1020057006260A patent/KR20050075356A/ko not_active Application Discontinuation
- 2003-10-02 BR BR0315247-2A patent/BR0315247A/pt not_active IP Right Cessation
- 2003-10-02 JP JP2004543136A patent/JP2006502219A/ja active Pending
- 2003-10-02 EP EP03774548A patent/EP1558588A4/de not_active Withdrawn
- 2003-10-02 CN CNA200380105737XA patent/CN1726198A/zh active Pending
- 2003-10-02 WO PCT/US2003/031413 patent/WO2004032840A2/en active Application Filing
- 2003-10-09 AR ARP030103684A patent/AR044193A1/es unknown
- 2003-10-09 TW TW092128029A patent/TW200418818A/zh unknown
2005
- 2005-04-10 IL IL167936A patent/IL167936A0/en unknown
- 2005-04-11 IS IS7798A patent/IS7798A/is unknown
- 2005-05-10 ZA ZA200503733A patent/ZA200503733B/en unknown
- 2005-05-10 NO NO20052267A patent/NO20052267L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2006502219A (ja)	2006-01-19
IL167936A0 (en)	2009-02-11
CN1726198A (zh)	2006-01-25
NZ539643A (en)	2006-11-30
EP1558588A4 (de)	2006-11-02
WO2004032840A3 (en)	2004-10-14
MXPA05003830A (es)	2005-06-23
WO2004032840A2 (en)	2004-04-22
RU2005114491A (ru)	2006-02-10
BR0315247A (pt)	2005-08-30
AR044193A1 (es)	2005-09-07
US7476743B2 (en)	2009-01-13
AU2003282665A1 (en)	2004-05-04
EP1558588A2 (de)	2005-08-03
CA2501938A1 (en)	2004-04-22
ZA200503733B (en)	2006-02-22
US20060189671A1 (en)	2006-08-24
TW200418818A (en)	2004-10-01
IS7798A (is)	2005-04-11
KR20050075356A (ko)	2005-07-20
PL375889A1 (en)	2005-12-12

Publication	Publication Date	Title
NO20045043L (no)	2005-02-08	Pyrimidinonforbindelser, sammensetninger og fremgangsmater
WO2003103575A3 (en)	2004-02-26	COMPOUNDS, COMPOSITIONS AND METHODS
WO2004018058A3 (en)	2004-07-01	Compounds, compositions, and methods
MY140169A (en)	2009-11-30	Compounds, compositions, and methods
WO2004009036A3 (en)	2004-08-19	Compounds compositions and methods
MXPA06012796A (es)	2007-05-09	Ciertas entidades quimicas, composiciones y metodos.
WO2006113432A3 (en)	2007-07-12	Compounds, compositions and methods
MY169308A (en)	2019-03-21	Treatment of tnf? related disorders
NO20021907L (no)	2002-06-07	Metoder og blandinger som anvender kinazolinoner
NO20026172D0 (no)	2002-12-20	Fremgangsmåter og blandinger ved anvendelse av kinazolinoner
DK1305286T3 (da)	2005-03-14	Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling
WO2003073999A3 (en)	2003-12-31	Pini-modulating compounds and methods of use thereof
NO20003600D0 (no)	2000-07-13	Kaliumkanal inhibitorer
WO2003074550A3 (en)	2003-12-04	Pin1-modulating compounds and methods of use thereof
NO20052267L (no)	2005-05-31	Forbindelser, Preparater og Metoder
AU2003252025A1 (en)	2004-02-02	Compounds, compositions, and methods
WO2004034972A3 (en)	2004-11-25	Compounds, compositions, and methods
WO2004064741A3 (en)	2005-01-27	Compounds, compositions, and methods
WO2005046588A3 (en)	2005-08-11	Compounds, compositions, and methods
NO20044530L (no)	2004-10-21	Fremgangsmate for behandling av kognitive forstyrrelser
WO2005042697A3 (en)	2005-09-29	Compounds, compositions and methods
WO2004032879A3 (en)	2004-07-15	Compounds, compositions, and methods
WO2004100873A3 (en)	2005-08-18	Compounds, compositions, and methods
WO2004024086A3 (en)	2004-07-22	Compounds, compositions and methods
WO2005062847A3 (en)	2006-03-30	Compounds, compositions and methods

Legal Events

Date	Code	Title	Description
2011-05-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application